ARL4C and endometrial cancer: It was observed that ARFRP1, ARL1, ARL10, ARL13B, ARL15, ARL2, ARL3, ARL4A, ARL4D, ARL5A, ARL5C, ARL8B, and TRIM23 showed low expression in endometrial cancer compared to the control, while ARF1, ARF3, ARF4, ARF5, ARF6, ARL11, ARL14, ARL16, ARL4C, ARL5B, ARL8A, ARL9, and SAR1B were overexpressed [53].